To address the inappropriate use of race from clinical guidelines and algorithms, clear guidance on the use of race as a biologic construct in research and publishing is required. This upstream guidance should support the downstream changes required in clinical guidelines and algorithms to prevent patient harm. In this session, participants will share experiences with updating guidelines and algorithms; discuss strategies to foster collaboration across the clinical and research communities; learn from existing collaborative efforts across specialty societies, research, and publishing; and support next steps to generate guidance on the use of race. 

Facilitators:

• Maureen Achebe, MD, MPH, Associate Professor of Medicine, Harvard Medical School, Clinical Director, Non-Malignant Hematology Clinic, Director, Brigham and Women's Hospital Sickle Cell Program 
• Christine Laine, MD, MPH, Editor in Chief & Senior Vice President, Annals of Internal Medicine, American College of Physicians